Dartmouth-Hitchcock Medical Center: Schizophrenia trials

The registry lists 27 Schizophrenia studies with Dartmouth-Hitchcock Medical Center as lead sponsor. 0 are open to participants now and 14 have results posted.

Phase 1 3Phase 2 2Phase 4 5No phase 17(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• Lifestyle Intervention for Young Adults With Serious Mental IllnessCompletedNCT02815813Not applicableResults posted
• Randomized Controlled Trial (RCT) of a Motivational Decision Support SystemCompletedNCT02086162Not applicableResults posted
• Development of a Mobile System for Self-management of Schizophrenia (SOS)CompletedNCT01969500Not applicableResults posted
• Cannabis, Schizophrenia and Reward: Self-Medication and Agonist Treatment?CompletedNCT01964404Phase 1Results posted
• A New Paradigm for Illness Monitoring and Relapse Prevention in SchizophreniaCompletedNCT01952041Not applicableResults posted
• Clozapine for Cannabis Use in SchizophreniaCompletedNCT01639872Phase 4Results posted
• Electronic Decision Support Systems for Smokers With Severe Mental IllnessCompletedNCT01412866Not applicableResults posted
• Risperidone and Desipramine in Alcohol Use and SchizophreniaCompletedNCT01411085Phase 2Results posted
• Cannabis and Schizophrenia: Self-Medication and Agonist TreatmentCompletedNCT00946348Phase 1Results posted
• First Episode Schizophrenia and Cannabis-Related Disorder StudyCompletedNCT00573287Not applicableResults posted
• Treatment of Schizophrenia and Comorbid Cannabis Use Disorder: Comparing Clozapine to Treatment-as-UsualCompletedNCT00498550Phase 4Results posted
• Effectiveness of the Screen, Test, Immunize, Reduce Risk, and Refer (STIRR) Intervention for People With Both a Mental and Substance Abuse DisorderCompletedNCT00316303Phase 2Results posted
• Efficacy of Quetiapine in the Treatment of Patients With Schizophrenia and a Comorbid Substance Use DisorderCompletedNCT00156715Phase 4Results posted
• Risperidone Long-acting Versus Oral Risperidone in Patients With Schizophrenia and Alcohol Use DisorderCompletedNCT00130923Phase 4Results posted
• Peer-delivered and Technology-Assisted Integrated Illness Management and RecoveryCompletedNCT04481737Not applicable
• The Appeal and Impact of E-cigarettes in Smokers With SMICompletedNCT03050853Not applicable
• Comparing Mobile Health (mHealth) and Clinic-Based Self-Management Interventions for Serious Mental IllnessCompletedNCT02421965Not applicable
• Evaluation of A Statewide Program to Prevent Early Mortality and to Promote Fitness in Persons With SMICompletedNCT02334280Not applicable
• Evaluation of the In SHAPE Fitness Intervention for Adults With Serious Mental IllnessCompletedNCT02334228Not applicable
• Self-Management Training and Automated Telehealth to Improve SMI Health OutcomesCompletedNCT02188732Not applicable
• Health Promotion and Fitness for Younger and Older Adults With SMICompletedNCT02090335Not applicable
• Thinking Skills for Work in Severe Mental IllnessCompletedNCT01926613Not applicable
• Individually Based Psychosocial Rehabilitation for Older People With Serious Mental Illness (SMI)CompletedNCT00817154Phase 1
• Medication Adherence in Older Adults With Serious Mental IllnessCompletedNCT00224380Not applicable
• Health Care Management and Rehabilitation Skills Training for Treating Serious Mental Illness in Older PeopleCompletedNCT00169052Not applicable
• Alcoholism and Schizophrenia: Effects of ClozapineTerminatedNCT00169026Phase 4
• Family Intervention for Mental Illness and Substance AbuseCompletedNCT00043693Not applicable